Use of Polyphenolic Compounds in Dermatologic Oncology

Am J Clin Dermatol. 2016 Aug;17(4):369-85. doi: 10.1007/s40257-016-0193-5.

Abstract

Polyphenols are a widely used class of compounds in dermatology. While phenol itself, the most basic member of the phenol family, is chemically synthesized, most polyphenolic compounds are found in plants and form part of their defense mechanism against decomposition. Polyphenolic compounds, which include phenolic acids, flavonoids, stilbenes, and lignans, play an integral role in preventing the attack on plants by bacteria and fungi, as well as serving as cross-links in plant polymers. There is also mounting evidence that polyphenolic compounds play an important role in human health as well. One of the most important benefits, which puts them in the spotlight of current studies, is their antitumor profile. Some of these polyphenolic compounds have already presented promising results in either in vitro or in vivo studies for non-melanoma skin cancer and melanoma. These compounds act on several biomolecular pathways including cell division cycle arrest, autophagy, and apoptosis. Indeed, such natural compounds may be of potential for both preventive and therapeutic fields of cancer. This review evaluates the existing scientific literature in order to provide support for new research opportunities using polyphenolic compounds in oncodermatology.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Humans
  • Polyphenols / therapeutic use*
  • Skin Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents, Phytogenic
  • Polyphenols